APPLICATIONS PUBLISHED 31 AUGUST 2005

An allergen dosage form
Alk-Abello 1567123*

Pharmaceutical compsns and dosage forms for buccal and sub-lingual delivery of tizanidine and methods of administering tizandrine sublingually or buccally
Teva Pharmaceutical Industries 1567124*

Pharmaceutical compsns suitable for the treatment of ophthalmic diseases
Gasco, Maria Rosa; Zara, Gian Paolo 1567125*

Concentrated liquid valdecoxib compsns
Pharmacia 1567126*

Method of modifying the release profile of sustained release compsns
Alkermes Controlled Therapeutics 1567127*

Process for obtaining bacterium-size particles
Horvath, Istvan 1567128*

Artificial blood on the basis of encapsulated haemoglobin
Horvath, Istvan 1567129*

Method of drug loading in liposomes by gradient
Gilead Sciences 1567130*

Buproprion hydrochloride solid dosage forms
Ranbaxy Laboratories 1567131*

Shape-retentive hydrogel particle aggregates and their uses
Access Pharmaceuticals 1567132*

Pharmaceutical antiviral compsns
Glaxo Group; SmithKline Beecham 1567133*

Pharmaceutical compsns comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
Janssen Pharmaceutica 1567134*

Pulverant formulation for inhalation containing tiotropium
Boehringer Ingelheim Pharmaceuticals 1567135*

PDE4 and PDE3/4 inhibitors for use in the treatment of cachexia
ALTANA Pharma 1567136*

Use of reservatrol for the preparation of a medicament useful for the treatment of influenza virus infections
SIGMA-TAU Industrie Farmaceutiche Riunite 1567137*

Use of diamide derivatives for inhibiting chronic tissue transplant rejection
Genzyme 1567138*

New synergistic combination comprising roflumilast and formoterol
ALTANA Pharma 1567139*

Synergistic combination comprising roflumilast and (R,R')-formoterol
ALTANA Pharma 1567140*

Labelled microphage scavenger receptor antagonists for imaging cardiovascular diseases
GE Healthcare 1567141*

Treatment of lung cells with histone deacetylase inhibitors
Errant Gene Therapeutics 1567142*

Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
Symrise 1567143*

Method of making, and the use of cytotoxic agents containing elemental selenium
Medical College of Wisconsin Research Foundation 1567144*

Analgesic uses of norketamine and ketamine/norketamine prodrugs
Yaupon Therapeutics 1567145*

Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
Schwartz Pharma 1567146*

Water-soluble anionic bacterio-chlorophyll derivatives and their uses
Yeda Research and Development 1567147*

Methods of using and compsns comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration
Celgene 1567148*

Pharmaceutical compsns comprising beta-3-adrenoreceptor agonists and antimuscarinic agents
Boehringer Ingelheim International 1567149*

Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
Sanofi-Aventis 1567150*

3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer
Vernalis (Cambridge); Cancer Research Technology; The Institute of Cancer Research 1567151*

Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
Teva Pharmaceutical 1567152*

Shivering suppression during cooling to lower body temperature
Medivance 1567153*

Methods and compsns using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
Celgene 1567154*

Administration of dendritic cells partially matured in vitro for the treatment of tumours
NorthWest Biotherapeutics 1567155*

Hydroxypyridinones for the local treatment of skin microcirculatory disorders
Relivia 1567156*

Methods of using and compsns comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
Celgene 1567157*

Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions
Egis Gyogyszergyar 1567159*

Method of treatment of myocardial infarction
The Scripps Research Institute 1567160*

Pharmaceutical compsn of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof
Vela Pharmaceuticals 1567161*

Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
Vela Pharmaceuticals 1567162*

Method of treating nausea, vomiting, retching or any combination thereof
Dynogen Pharmaceuticals 1567163*

Use of loxapine or amoxapine for the manufacture of a medicament for the treatment of pain
Alexza Molecular Delivery 1567164*

Water-soluble mesoporphyrin compounds and methods of preparation
InfaCare Pharmaceutical 1567165*

Superoxide dismutase mimics for the treatment of ocular disorders and diseases
Alcon 1567166*

Methods for treating gastroesophageal reflux disease
Crocept Therapeutics 1567167*

Gemcitabine prodrugs, pharmaceutical compsns and uses thereof
Xenoport 1567169*

Use of beta-glucans against biological warfare weapons and pathogens including anthrax
Biopolymer Engineering 1567170*

New use of dextran sulphate
Prophy Med 1567171*

Formulations useful against hepatitis C virus infections
GPC Biotech 1567172*

A protectant for UV-induced skin damage
Atrix Laboratories 1567173*

Compsns for diabetes treatment and prophylaxis
Ayervedic-Life International 1567174*

Sterile immunogenic non-tumourigenic tumour cell compsns and methods
Intracel Resources 1567175*

An anti-arrhythmic compound from king cobra venom and a process of purification thereof
Council of Scientific and Industrial Research 1567176*